Oncology News

Oncology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Yahav D et al. – Antiviral prophylaxis reduced mortality with a small NNT in the post–engraftment setting of allogeneic HSCT. In the pre–engraftment phase and during chemotherapy only viral–related morbidity was reduced.


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address